RxDoctor Payments DataLook up a doctor →

John Weber, MD

Gastroenterology · Troy, MINPI 1770568289

Payments from drug & device makers

$969,370in general payments, 2019–2025

Across 482 payments — averaging $2011.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$605K
  • Genentech, Inc.$100K
  • Roche Products Limited$89K
  • Takeda Pharmaceuticals U.S.A., Inc.$57K
  • Gilead$48K
  • E.r. Squibb & Sons, L.L.C.$37K
  • plus $33K from 24 others
$10,070in research payments, 2019–2025

Across 2 payments — averaging $5035.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$10K

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$969,370 in reported general payments places this provider in the 95th percentile of 497 gastroenterology providers in Michigan.

See all gastroenterology providers in Michigan

Medicare billing

Part B allowed, 2024
$159,754
Medicare patients
572
Services billed
4,641

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Troy

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →